SOHLH2 (spermatogenesis and oogenesis specific basic helix-loop-helix 2)

2019-03-01   Flavia R Mangone  , Ana Carolina Pavanelli  , Maria A. Nagai  

Identity

HGNC
LOCATION
13q13.3
LOCUSID
ALIAS
SOSF2,SPATA28,TEB1,bHLHe81

Abstract

Review on SOHLH2, with data on DNA, on the protein encoded, and where the gene is implicated.

DNA/RNA

Note

Readthrough gene: CCDC169-SOHLH2 (Gene ID: 100526761). This locus represents naturally occurring read-through transcription between the neighboring CCDC169 (C13orf38 chromosome 13 open reading frame 38) and SOHLH2 (spermatogenesis and oogenesis specific basic helix-loop-helix 2) genes. The read-through transcript encodes a fusion protein that shares sequence identity with the products of each gene. [provided by RefSeq, Nov 2010] .

Description

DNA size: 46,408 bp (NG_033786.1); mRNA size: 2125 bp (NM_017826.3); 11 exons.
SOHLH2 was mapped to human chromosome 13q13 and consist of 46,408 base pairs, starting at base pair 36,168,208 and ending at base pair 36,214,615 according to last released (GRCh38/hg38).
This gene encodes one of the testis-specific transcription factors which are essential for spermatogenesis, oogenesis, and folliculogenesis. This gene is located on chromosome 13. The proteins encoded by this gene and another testis-specific transcription factor, SOHLH1, can form heterodimers, in addition to homodimers. There is a read-through locus (GeneID: 100526761) that shares sequence identity with this gene and the upstream CCDC169 (GeneID: 728591). Alternatively, spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2013].
It has been described that the promoter region of SOHLH2 gene includes a CpG island, and SOHLH2 promoter hypomethylation was detected in 44% of 61 cancer cell lines and 30% of the primary tumours representing the major tumour types (Shen et al., 2007).

Transcription

Two transcript variants encoding different isoforms have been found for this gene.
NM_017826.3 spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 isoform 1: Protein (NP_060296.2) - 425 aa; mRNA (NM_017826.3) - 2125 bp; Description: This variant (1) represents the longer transcript and encodes the longer isoform (2).
NM_001282147.1 spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 isoform 2: Protein (NP_001269076.1) - 225 aa; mRNA (NM_001282147.1) - 1936 bp corresponding to 7 exons (Ensembl); Description: This variant lacks several exons but has an alternate 3 terminal exon, compared to variant 1. The resulting isoform is much shorter and has a distinct C-terminus, compared to isoform 1.

Proteins

Note

Molecular weight: NP_060296.2 ~46.9 kDa, 425aa; NP_001269076.1 ~25.1 kDa, 225 aa
Atlas Image
Figure 1 - Schematic representation of the human SOHLH2 protein SOHLH2 is a 425aa protein with one basic helix-loop-helix DNA-binding motif (bHLH, 197-257aa)

Description

SOHLH2 is a ~46.9 kDa protein (initially described as a 51kDa (Ballow et al., 2006)), composed of 425 amino acids, with an isoelectric point of 7.1377. SOHLH2 has a basic helix-loop-helix DNA-binding (bHLH) motif of 60aa (197-257aa) thus it has being described as a transcription factor (figure 1). The amino-terminal portion of bHLH corresponds to the basic domain, enabling the binding of the protein to its consensus sequence at the DNA, known as E-Box. The HLH portion is at the carboxy-terminal portion of bHLH and is a structure covering two α -helices connected by a loop which is responsible for the interactions with other protein subunits to form homo- and heterodimeric complexes (Jones, 2004; Gyoja, 2017).

Expression

SOHLH2 protein expression is observed in the nuclei of oocytes, and weak staining is present in the cytoplasm of theca cells and granular cells in the ovary. The SOHLH2 transcripts expression are detectable specifically in the oocytes of small follicles of female embryonic gonad. In adult ovaries, SOHLH2 protein is present in primordial follicles and absent in growing oocytes (Ballow et al., 2006). In testis, SOHLH2 is found mainly in spermatogonia and Sertoli cells in seminiferous tubule and Leydig cells outside of seminiferous tubules (Ballow et al., 2006; Zhang et al., 2015). Although SOHLH2 has been initially described in testis and oocytes, it is widely expressed in normal adult human tissues. The expression of SOHLH2 is also observed in the cytoplasm of the three kinds of muscle tissues: skeletal, cardiac and smooth. SOHLH2 protein expression was also found in other tissues derived from embryonic mesoderm such as kidney and uterine tube (Zhang et al., 2015). In neurons, Sohlh2 were detected mainly in the nuclei, while it was not detectable by IHC in neuroglial cells. The expression of SOHLH2 gene was also detected in some other tissues derived from embryonic ectoderm including iris, ciliary body, and retina (Zhang et al., 2015).

Localisation

SOHLH2 is an intracellular protein present predominantly in the nucleus but also in the cytoplasm of specific cell types (Zhang et al., 2015; Shin et al., 2017). Its translocation from the cytoplasm is associated with expression of SOHLH1 (Shin et al., 2017).

Function

Tissue-specific basic helix-loop-helix (bHLH) transcription factors play critical roles in cell differentiation
SOHLH2 is described as a transcription regulator of both male and female germline differentiation. SOHLH2, together with SOHLH1, regulates oocyte growth and differentiation (Shin et al., 2017). SOHLH proteins modulate the expression of genes involved in spermatogonial stem cells maintenance (SSC), such as RET, GFRA1, NANOS2, and POU5F1. Also, it regulates the expression of genes essential for spermatogonial differentiation such as KIT, and SOX3 (Suzuki et al., 2012).
According to Toyoda et al. SOHLH2 forms a ternary complex with SOHLH1, and SP1 and cooperatively regulates the transcription of SOHLH1 gene (Toyoda et al., 2014).
Atlas Image
Figure 2 - Schematic representation of the mechanism of action of SOHLH2. SOHLH2 negatively regulates cell proliferation trough upregulation of APC expression and inhibition of Wnt/βcatenin signaling and suppresses migration and invasion by down-regulation of IL-8. SOHLH2 - spermatogenesis and oogenesis specific basic helix-loop-helix 2; APC - adenomatosis polyposis coli/APC regulator of WNT signaling pathway; IL-8 - Interleukin 8 (Zhang et al., 2016; Ji et al, 2016)

Homology

Although SOHLH2 was identified as a homologue of SOHLH1, their limited homology is confined to the bHLH domains (~50%) (Suzuki et al., 2012). The bHLH protein domain of SOHLH2 is the most conserved region among different species (Ballow et al., 2006). The described identity among mouse SOHLH2 protein with the rat and human orthologue is 84% and 50%, respectively (Ballow et al., 2006).

Implicated in

Top note
SOHLH2 is a transcription regulator involved in spermatogenesis and oogenesis, but also in Cancer: Basic helix-loop-helix (bHLH) proteins play several roles in tumorigenesis, such as cell differentiation, cell cycle arrest and apoptosis (Sun et al., 2007).
Entity name
Spermatogenesis and Azoospermia
Note
Spermatogenesis is a process by which male gametes, known as sperm, are formed from primordial germ cells (spermatogonia).
Hao et al. (2008) have observed that mice null for Sohlh2 (Sohlh2 -/-) showed testis with a significantly diminished size. Moreover, based on testicular atrophy, functional studies have shown that type A spermatogonia differentiation was interrupted in SOHLH2 null mice (Hao et al., 2008).
Azoospermia is a condition characterized by the absence of sperm cells in the semen, classified into two groups: obstructive azoospermia (OA) and non-obstructive azoospermia (NOA). In a Chinese study evolving a cohort of 361 of patients, Song et al. have described two variants, with different risk impact of NOA development. The rs6563386 variant conferred a higher risk of NOA while the rs1328626 variant was associated with lower risk of NOA, suggesting a direct relation of SOHLH2 gene to NOA development (Song et al., 2015).
Entity name
Premature Ovarian Failure
Note
The Premature Ovarian Failure (POF), sometimes referred to as Premature Menopause, is a human female gonadal failure before forty years old. Eleven variants of SOHLH2 were described in a series of 561 POF patients, suggesting that this gene might play a role in human POF etiology (Qin et al., 2014). In another work, the association of SOHLH2 with POF development was suggested after exposure of mice to common endocrine disrupting chemicals (EDCs) present in the environmental. These authors found that after exposure to EDCs, the SOHLH2 protein and mRNA were downregulated and as a consequence, these mice presented an impaired primordial follicular development (Tran et al., 2018).
Entity name
Epithelial Ovarian Cancer (EOC)
Note
SOHLH2 seems to be related to EOC tumorigenesis. The SOHLH2 immunostaining was evaluated in tumors from 65 EOC patients, and it was observed that those with SOHLH2 negative tumors presented lower overall survival as compared to positive tumors. In vitro studies were conducted to assess the impact of SOHLH2 in the cellular growth of EOC derived cell lines and obtained data showed that SOHLH2 overexpression inhibited proliferation of HO8910 and OVCAR3 cells. In accordance with that, the injection of HO8910 overexpressing SOHLH2 in nude mice caused a lower tumor growth rate as compared to the control group. The mechanism involved in this reduced tumor growth seems to be associated with the induction of CDKN1A (also designated WAF1/CIP1 or "p21") and inhibition of CCND1 (cyclin D1) expression as observed in HO8910 overexpressing SOHLH2. These data suggest that SOHLH2 might act as a tumor suppressor in EOC (Zhang et al., 2014).
In another study, the SOHLH2 reduction expression was significantly associated with distant metastasis as compared to borderline ovarian tumors and EOC without metastasis. Taking all these into consideration, SOHLH2 seems to play a role in EOC tumorigenesis and invasion (Zhang et al., 2016).
Entity name
Breast Cancer
Note
The overexpression of SOHLH2 in MDA-MB-231 cell line inhibited metastasis and epithelial-mesenchymal transition (EMT) by controlling transcription of CXCL8 (IL-8) through binding to its promoter region. On the other hands, SOHLH2 silence increased migration and invasion, suggesting that this protein may negatively regulate metastasis and play an important role in EMT (Ji et al., 2016).
Primary breast tumors express reduced levels of SOHLH2 in comparison with normal tissue (Zhang et al., 2019). Also, SOHLH2 expression is associated to cellular proliferation in vitro and tumor growth in vivo acting as a tumor suppressor gene. The tumor suppressor effects on breast cancer seem to occur due to SOHLH2 inhibition of WNT/β-catenin through the increase of APC (Zhang et al., 2019) (figure 2).
Previous data from our group have shown the association between SOHLH2 and triple negative breast cancer (TNBC). Patients with TNBC with reduced expression of SOHLH2 show shorter disease-free and a tendency to lower overall survival rates compared to patients with tumors with increased expression of SOHLH2, suggesting that SOHLH2 expression might be a potential candidate biomarker with potential prognostic value for TNBC. (De Alcantara Filho et al., 2018)

Article Bibliography

Pubmed IDLast YearTitleAuthors
167651022006Sohlh2 is a germ cell-specific bHLH transcription factor.Ballow DJ et al
288049532017Basic helix-loop-helix transcription factors in evolution: Roles in development of mesoderm and neural tissues.Gyoja F et al
183397732008Sohlh2 knockout mice are male-sterile because of degeneration of differentiating type A spermatogonia.Hao J et al
273844822016Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.Ji S et al
151864842004An overview of the basic helix-loop-helix proteins.Jones S et al
245248322014Novel variants in the SOHLH2 gene are implicated in human premature ovarian failure.Qin Y et al
179670632007Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.Shen L et al
285046552017Transcription factors SOHLH1 and SOHLH2 coordinate oocyte differentiation without affecting meiosis I.Shin YH et al
254636352015Association of genetic variants in SOHLH1 and SOHLH2 with non-obstructive azoospermia risk in the Chinese population.Song B et al
236411482007bHLH-Orange Transcription Factors in Development and Cancer.Sun H et al
220567842012SOHLH1 and SOHLH2 coordinate spermatogonial differentiation.Suzuki H et al
250036262014Auto-regulation of the Sohlh1 gene by the SOHLH2/SOHLH1/SP1 complex: implications for early spermatogenesis and oogenesis.Toyoda S et al
299696522018Depletion of follicles accelerated by combined exposure to phthalates and 4-vinylcyclohexene diepoxide, leading to premature ovarian failure in rats.Tran DN et al
261538942016Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.Zhang H et al
248582062014Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.Zhang H et al
307202322019Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.Zhang X et al

Other Information

Locus ID:

NCBI: 54937
MIM: 616066
HGNC: 26026
Ensembl: ENSG00000120669

Variants:

dbSNP: 54937
ClinVar: 54937
TCGA: ENSG00000120669
COSMIC: SOHLH2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000120669ENST00000317764Q9NX45
ENSG00000120669ENST00000379881Q9NX45

Expression (GTEx)

0
5
10
15
20
25

References

Pubmed IDYearTitleCitations
362871772023Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription.1
362871772023Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription.1
338756422021Germline variants at SOHLH2 influence multiple myeloma risk.6
341583922021SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.3
338756422021Germline variants at SOHLH2 influence multiple myeloma risk.6
341583922021SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.3
313186832020Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1α/CA9 signaling pathway.3
326902702020Intronic variation of the SOHLH2 gene confers risk to male reproductive impairment.5
313186832020Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1α/CA9 signaling pathway.3
326902702020Intronic variation of the SOHLH2 gene confers risk to male reproductive impairment.5
307202322019Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.7
307202322019Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.7
261538942016Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.11
273844822016Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.3
261538942016Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.11

Citation

Flavia R Mangone ; Ana Carolina Pavanelli ; Maria A. Nagai

SOHLH2 (spermatogenesis and oogenesis specific basic helix-loop-helix 2)

Atlas Genet Cytogenet Oncol Haematol. 2019-03-01

Online version: http://atlasgeneticsoncology.org/gene/55087/js/lib/cancer-prone-explorer/